Suchergebnisse - "Yuan, Shengxian"

PubPharm (39)

1

Development and comprehensive validation of a predictive prognosis model for very early HCC recurrence within one year after curative resection : a multicenter cohort study

enthalten in: International journal of surgery (London, England) | 2024

von Liu, L. | Qin, S. | Lin, K. | +8

2

Paradoxical activation of oncogenic signaling as a cancer treatment strategy

enthalten in: Cancer discovery | 2024

von Dias, M. | Friskes, A. | Wang, S. | +35

3

Spatial multimodal analysis revealed tertiary lymphoid structures as a risk stratification indicator in combined hepatocellular-cholangiocarcinoma

enthalten in: Cancer letters | 2024

von Gan, X. | Dong, W. | You, W. | +10

4

Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs

enthalten in: Gastroenterology | 2024

von Wang, H. | Yuan, S. | Zheng, Q. | +16

5

Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2

enthalten in: JHEP reports : innovation in hepatology | 2023

von Wang, S. | Zhou, Y. | Yu, R. | +22

6

Interference sequence aiming at tumor prevention or treatment and application thereof

enthalten in: Europäisches Patentamt | 2023

von ZHOU WEIPING | YUAN SHENGXIAN | ZHANG ZHENGWEI | +2

7

Interference sequence aiming at tumor prevention or treatment and application thereof

enthalten in: Europäisches Patentamt | 2023

von ZHOU WEIPING | YUAN SHENGXIAN | ZHANG ZHENGWEI | +2

8

Paradoxical activation of oncogenic signaling as a cancer treatment strategy

enthalten in: bioRxiv.org | 2023

von Dias, M. | Friskes, A. | Wang, S. | +34

9

Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancer

enthalten in: EBioMedicine | 2023

von Zhou, Y. | Wang, S. | Wu, W. | +14

10

High-throughput sequencing approach for the identification of lncRNA biomarkers in hepatocellular carcinoma and revealing the effect of ZFAS1/miR-150-5p on hepatocellular carcinoma progression

enthalten in: PeerJ | 2023

von Zhu, P. | Pei, Y. | Yu, J. | +12